Compare IQIYI Inc - ADR (IQ) vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IQIYI Inc - ADR vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? IQIYI Inc - ADR trades at $0.94 (market cap $918.03M), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $37.8 (market cap $63.89B). The key difference: RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) is far larger — about 69.6× IQIYI Inc - ADR's market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays a 2.47% dividend while IQIYI Inc - ADR pays none. Which is the better fit depends on your goals.
| IQ | RELX | |
|---|---|---|
Market Cap | $918.03M | $63.89B |
Volume | 10,354,180 | 2,760,502 |
Sector | Media | Industrials |
52-Week High | $2.35 | $46.80 |
52-Week Low | $0.86 | $27.73 |
Typical Hold Time | 55 Days | — |
Enterprise Value | $2.41B | $75.40B |
Dividend Yield | — | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IQ trades at $0.99, down 2.78% today, with a neutral technical signal. The company reported a net loss of $206 million in 2025 despite beating EPS estimates in recent quarters. Revenue has declined from $31.9B in 2023 to $27.3B in 2025. Analyst sentiment is mixed with a 50% buy rating. Recent news highlights AI-driven content initiatives, including the successful 'The Ferry Man' series.
The outlook is cautious; while AI innovation offers growth potential, persistent revenue declines and negative margins pose risks. The stock's low P/S and P/B ratios suggest undervaluation, but profitability challenges and high debt levels require careful monitoring. Upside depends on successful execution of AI content strategy and return to revenue growth.
RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.
The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IQIYI Inc - ADR
iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Read more on IQ →About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)
RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.
Read more on RELX →
